Join the global fight to eradicate human disease. The need to develop new strategies to combat diseases remains a major global challenge. By equipping you with an understanding of the mechanisms underpinning both infectious and non-infectous diseases, this degree aims to enhance your employability and prepare you to tackle this challenge.
YouÕll learn about the latest molecular, genetic and cellular approaches being used to understand, diagnose and treat human disease, including traditional methods such as polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA), and novel methods involving genome and proteome analysis.
YouÕll also have the opportunity to investigate the role of the immune system in the response to infection and disease, covering topics such as innate and adaptive immunity, allergy and immune evasion.
On this programme at University of Leeds youÕll gain an overview of a range of modern techniques and methodologies that underpin contemporary biomolecular sciences. YouÕll investigate five topic areas: molecular biology, structural biology, cell imaging and flow cytometry, high throughput techniques and transgenic organisms.
Career
The strong research element of the Infection, Immunity and Human Disease MSc, along with the specialist and generic skills you develop, mean youÕll graduate equipped for a wide range of careers.
The graduates work in a diverse range of areas, ranging from bioscience-related research through to scientific publication, teacher training, health and safety and pharmaceutical market research.
Links with industry
We have a proactive Industrial Advisory Board who advise us on what they look for in graduates and on employability-related skills within our programmes.
We collaborate with a wide range of organisations in the public and commercial sectors. Many of these are represented on our Industrial Advisory Board. They include:
- GlaxoSmithKline
- Ernst and Young
- The Food and Environment Research Agency
- The Health Protection Agency
- MedImmune
- Thermofisher Scientific
- Hays Life Sciences
- European Bioinformatics Institute
- Smaller University spin-out companies, such as Lumora
